Cyclopamine sensitizes TRAIL-resistant gastric cancer cells to TRAIL-induced apoptosis via endoplasmic reticulum stress-mediated increase of death receptor 5 and survivin degradation

Yoo Jin Na, Dae Hee Lee, Jung Lim Kim, Bo Ram Kim, Seong Hye Park, Min Jee Jo, Soyeon Jeong, Hong Jun Kim, Suk young Lee, Yoon A. Jeong, Sang Cheul Oh

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is one of the most effective cancer treatments owing to its ability to selectively kill cancer cells, without affecting normal cells. However, it has been reported that several gastric cancer cells show resistance to TRAIL because of a scarcity of death receptor 5 (DR5) expressed on the cell surface. In this study, we show that cyclopamine sensitizes gastric cancer cells to TRAIL-induced apoptosis by elevating the expression of DR5. Interestingly, survivin hampers the existence of DR5 protein under normal conditions and cyclopamine decreases the expression of survivin, thus acting as a TRAIL sensitizer. Mechanistically, cyclopamine induces endoplasmic reticulum (ER) stress via reactive oxygen species (ROS) and CHOP, the last protein of the ER stress pathway and it regulates the proteasome degradation of survivin. Taken together, our results indicate that cyclopamine can be used for combination therapy in TRAIL-resistant gastric cancer cells.

Original languageEnglish
Pages (from-to)147-156
Number of pages10
JournalInternational Journal of Biochemistry and Cell Biology
Volume89
DOIs
Publication statusPublished - 2017 Aug 1

Fingerprint

TNF-Related Apoptosis-Inducing Ligand
TNF-Related Apoptosis-Inducing Ligand Receptors
Endoplasmic Reticulum Stress
Stomach Neoplasms
Cells
Apoptosis
Degradation
Oncology
Proteasome Endopeptidase Complex
Reactive Oxygen Species
Proteins
Tumor Necrosis Factor-alpha
Ligands
cyclopamine
Neoplasms

Keywords

  • CHOP
  • Cyclopamine
  • Death receptor 5
  • Survivin
  • TRAIL-resistance

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Cyclopamine sensitizes TRAIL-resistant gastric cancer cells to TRAIL-induced apoptosis via endoplasmic reticulum stress-mediated increase of death receptor 5 and survivin degradation. / Na, Yoo Jin; Lee, Dae Hee; Kim, Jung Lim; Kim, Bo Ram; Park, Seong Hye; Jo, Min Jee; Jeong, Soyeon; Kim, Hong Jun; Lee, Suk young; Jeong, Yoon A.; Oh, Sang Cheul.

In: International Journal of Biochemistry and Cell Biology, Vol. 89, 01.08.2017, p. 147-156.

Research output: Contribution to journalArticle

Na, Yoo Jin ; Lee, Dae Hee ; Kim, Jung Lim ; Kim, Bo Ram ; Park, Seong Hye ; Jo, Min Jee ; Jeong, Soyeon ; Kim, Hong Jun ; Lee, Suk young ; Jeong, Yoon A. ; Oh, Sang Cheul. / Cyclopamine sensitizes TRAIL-resistant gastric cancer cells to TRAIL-induced apoptosis via endoplasmic reticulum stress-mediated increase of death receptor 5 and survivin degradation. In: International Journal of Biochemistry and Cell Biology. 2017 ; Vol. 89. pp. 147-156.
@article{3616a026793949e8ad5f41b3651d62de,
title = "Cyclopamine sensitizes TRAIL-resistant gastric cancer cells to TRAIL-induced apoptosis via endoplasmic reticulum stress-mediated increase of death receptor 5 and survivin degradation",
abstract = "Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is one of the most effective cancer treatments owing to its ability to selectively kill cancer cells, without affecting normal cells. However, it has been reported that several gastric cancer cells show resistance to TRAIL because of a scarcity of death receptor 5 (DR5) expressed on the cell surface. In this study, we show that cyclopamine sensitizes gastric cancer cells to TRAIL-induced apoptosis by elevating the expression of DR5. Interestingly, survivin hampers the existence of DR5 protein under normal conditions and cyclopamine decreases the expression of survivin, thus acting as a TRAIL sensitizer. Mechanistically, cyclopamine induces endoplasmic reticulum (ER) stress via reactive oxygen species (ROS) and CHOP, the last protein of the ER stress pathway and it regulates the proteasome degradation of survivin. Taken together, our results indicate that cyclopamine can be used for combination therapy in TRAIL-resistant gastric cancer cells.",
keywords = "CHOP, Cyclopamine, Death receptor 5, Survivin, TRAIL-resistance",
author = "Na, {Yoo Jin} and Lee, {Dae Hee} and Kim, {Jung Lim} and Kim, {Bo Ram} and Park, {Seong Hye} and Jo, {Min Jee} and Soyeon Jeong and Kim, {Hong Jun} and Lee, {Suk young} and Jeong, {Yoon A.} and Oh, {Sang Cheul}",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.biocel.2017.06.010",
language = "English",
volume = "89",
pages = "147--156",
journal = "International Journal of Biochemistry and Cell Biology",
issn = "1357-2725",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Cyclopamine sensitizes TRAIL-resistant gastric cancer cells to TRAIL-induced apoptosis via endoplasmic reticulum stress-mediated increase of death receptor 5 and survivin degradation

AU - Na, Yoo Jin

AU - Lee, Dae Hee

AU - Kim, Jung Lim

AU - Kim, Bo Ram

AU - Park, Seong Hye

AU - Jo, Min Jee

AU - Jeong, Soyeon

AU - Kim, Hong Jun

AU - Lee, Suk young

AU - Jeong, Yoon A.

AU - Oh, Sang Cheul

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is one of the most effective cancer treatments owing to its ability to selectively kill cancer cells, without affecting normal cells. However, it has been reported that several gastric cancer cells show resistance to TRAIL because of a scarcity of death receptor 5 (DR5) expressed on the cell surface. In this study, we show that cyclopamine sensitizes gastric cancer cells to TRAIL-induced apoptosis by elevating the expression of DR5. Interestingly, survivin hampers the existence of DR5 protein under normal conditions and cyclopamine decreases the expression of survivin, thus acting as a TRAIL sensitizer. Mechanistically, cyclopamine induces endoplasmic reticulum (ER) stress via reactive oxygen species (ROS) and CHOP, the last protein of the ER stress pathway and it regulates the proteasome degradation of survivin. Taken together, our results indicate that cyclopamine can be used for combination therapy in TRAIL-resistant gastric cancer cells.

AB - Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is one of the most effective cancer treatments owing to its ability to selectively kill cancer cells, without affecting normal cells. However, it has been reported that several gastric cancer cells show resistance to TRAIL because of a scarcity of death receptor 5 (DR5) expressed on the cell surface. In this study, we show that cyclopamine sensitizes gastric cancer cells to TRAIL-induced apoptosis by elevating the expression of DR5. Interestingly, survivin hampers the existence of DR5 protein under normal conditions and cyclopamine decreases the expression of survivin, thus acting as a TRAIL sensitizer. Mechanistically, cyclopamine induces endoplasmic reticulum (ER) stress via reactive oxygen species (ROS) and CHOP, the last protein of the ER stress pathway and it regulates the proteasome degradation of survivin. Taken together, our results indicate that cyclopamine can be used for combination therapy in TRAIL-resistant gastric cancer cells.

KW - CHOP

KW - Cyclopamine

KW - Death receptor 5

KW - Survivin

KW - TRAIL-resistance

UR - http://www.scopus.com/inward/record.url?scp=85020850489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020850489&partnerID=8YFLogxK

U2 - 10.1016/j.biocel.2017.06.010

DO - 10.1016/j.biocel.2017.06.010

M3 - Article

C2 - 28624529

AN - SCOPUS:85020850489

VL - 89

SP - 147

EP - 156

JO - International Journal of Biochemistry and Cell Biology

JF - International Journal of Biochemistry and Cell Biology

SN - 1357-2725

ER -